Mismatch repair deficiency in metastatic prostate cancer (PC): Response to PD-1 blockade and standard therapies

被引:0
|
作者
Graham, Laura
Montgomery, Robert B.
Cheng, Heather H.
Yu, Evan Y.
Alva, Ajjai Shivaram
Schweizer, Michael Thomas
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
194
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade
    Lee, Valerie
    Murphy, Adrian
    Le, Dung T.
    Diaz, Luis A., Jr.
    ONCOLOGIST, 2016, 21 (10): : 1200 - 1211
  • [22] Mismatch Repair Deficiency in High-Grade Meningioma: A Rare but Recurrent Event Associated With Dramatic Immune Activation and Clinical Response to PD-1 Blockade
    Dunn, Ian E.
    Du, Ziming
    Touat, Mehdi
    Sisti, Michael B.
    Wen, Patrick Y.
    Umeton, Renato
    Dubuc, Adrian M.
    Ducar, Matthew
    Canoll, Peter D.
    Severson, Eric
    Elvin, Julia A.
    Ramkissoon, Shakti H.
    Lin, Jia-Ren
    Cabrera, Lais
    Acevedo, Brenda
    Sorger, Peter K.
    Ligon, Keith L.
    Santagata, Sandro
    Reardon, David A.
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 12
  • [23] PD-1 blockade for the treatment of metastatic angiosarcoma
    Menzer, C.
    Reissner, L.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 101 - 102
  • [24] PD-1 blockade exploiting MMR deficiency
    David Killock
    Nature Reviews Clinical Oncology, 2017, 14 : 459 - 459
  • [25] Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+T cells in deficient mismatch repair colorectal cancer
    Sui, Qiaoqi
    Liu, Dingxin
    Jiang, Wu
    Tang, Jinghua
    Kong, Lingheng
    Han, Kai
    Liao, Leen
    Li, Yuan
    Ou, Qingjian
    Xiao, Binyi
    Liu, Guochen
    Ling, Yihong
    Chen, Jiewei
    Liu, Zexian
    Zuo, Zhixiang
    Pan, Zhizhong
    Zhou, Penghui
    Zheng, Jian
    Ding, Pei-Rong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
  • [26] Spatially resolved multi-region proteomics for prediction of clinical outcome in deficient mismatch repair metastatic colorectal cancer treated with PD-1 blockade
    Ardestani, Bahar Saberzadeh
    Liu, Zhenglong
    Stein, Mariam I.
    Sherman, Will
    Graham, Rondell P.
    Trussoni, Christy
    Ordog, Tamas
    Sinicrope, Frank A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers.
    Le, Dung T.
    Uram, Jennifer N.
    Wang, Hao
    Kemberling, Holly
    Eyring, Aleksandra
    Bartlett, Bjarne
    Goldberg, Richard M.
    Crocenzi, Todd S.
    Fisher, George A.
    Lee, James J.
    Greten, Tim F.
    Laheru, Dan
    Azad, Nilofer Saba
    Donehower, Ross C.
    Luber, Brandon
    Koshiji, Minori
    Eshleman, James R.
    Anders, Robert A.
    Vogelstein, Bert
    Diaz, Luis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [28] Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients
    Fang, Bangwei
    Wei, Yu
    Zeng, Hao
    Li, Yonghong
    Chen, Shouzhen
    Zhang, Tingwei
    Pan, Jian
    Wang, Beihe
    Wu, Junlong
    Jin, Shengming
    Gan, Hualei
    Hu, Mengna
    Zhang, Ding
    Ye, Dingwei
    Zhu, Yao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1541 - 1551
  • [29] Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients
    Bangwei Fang
    Yu Wei
    Hao Zeng
    Yonghong Li
    Shouzhen Chen
    Tingwei Zhang
    Jian Pan
    Beihe Wang
    Junlong Wu
    Shengming Jin
    Hualei Gan
    Mengna Hu
    Ding Zhang
    Dingwei Ye
    Yao Zhu
    Cancer Immunology, Immunotherapy, 2023, 72 : 1541 - 1551
  • [30] Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair-deficient, locally advanced rectal cancer
    Mi, Mi
    Ye, Chenyang
    Yuan, Ying
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01) : 361